newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Participate in Fireside Chat at 2023 Stifel Healthcare Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the